维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="OCIO EM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Antimyeloma effi cacy of plitidepsin ( aplidin (R) ) : from bench to the bedside 显示文摘	Ocio EM Mitsiades C Mateos MV	2007	Blood2007，，：	1
2	New drugs in multiple myeloma: mechanisms of action and phase I I II clinical findings 显示文摘	Ocio EM Mateos M V Maiso P et oi	2008	Lancet Oncol2008，9，12：	1
3	Immunophenotypic and cytogenetic comparison of waldenstroms macroglobulinemia with splenic marginal zone lymphoma 显示文摘	Ocio EM Hernamdez JM Mateo G	2005	Clin Lymph2005，5，4：	1
4	Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena 显示文摘	Ocio EM Sanchez - Guijo FM Diez - Campelo M	2005	Am J Hematol2005，78，：	1
5	Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena 显示文摘	Ocio EM Sanchez - Guijo FM Diez - Campelo M	2005	AmJ Hematol2005，78，4：	1
6	Efficacy of rit-uxinab in an aggressive from of multicentric Castleman disease asso-ciated with immune phenomena显示文摘	Ocio EM Sanchez-Guijo FM Diez-Campelo M	2005	Am JH ematol2005，78，4：	1
7	Aplidin, a marine organ- ism derived compound with potent antimyeloma activity in vitro and in vivo 显示文摘	Mitsiades CS Ocio EM Pandiella A	2008	Cancer Res2008，68，13：	1
8	CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype显示文摘	Paino T Ocio EM Paiva B	2012	Haematologica2012，97，7：	1
9	Efficacy of rituximab in an aggressive form of multicentric Castleman's disease associated with immune phenomena 显示文摘	Ocio EM Sanchez-Guijo FM Diez-Campelo M	2005	Am J Hematol2005，78，4：	1
10	The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance显示文摘	Maiso P Carvajal-Vergara X Ocio EM	2006	Cancer Res2006，66，：	1
11	New drugs and novel mechanisms of action in multiple myeloma in 2013:a report from the International Myeloma Working Group(IMWG)显示文摘	Ocio EM Richardson PG Rajkumar SV	2014	Leukemia2014，28，：	1
12	The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance 显示文摘	Maiso P Carvajal -Vergara X Ocio EM	2006	Cancer Res2006，66，11：	1
13	CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype显示文摘	Paino T Ocio EM Paiva B	2012	Haematologica2012，97，：	1
14	New drugs and nov- el mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) 显示文摘	Ocio EM Richardson PG Rajkumar SV	2014	Leu- kemia2014，28，3：	1
15	Etficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena显示文摘	Ocio EM Sanchez-Guijo FM Diez-Campdo M	2005	Am J Hematol2005，78，4：	1
16	6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis 显示文摘	Ocio EM Schop RF Gonzalez B	2007	Br J Haematol2007，136，1：	1
17	Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena显示文摘	Ocio EM Sanchez-Guijo FM Diez-cpelo M	2005	Am J Hematol2005，78，4：	1
18	Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobuline mia with splenic marginal zone lymphoma显示文摘	Ocio EM Hernandez JM Mateo G	2005	Clin Lymphoma2005，5，4：	1
19	The histone deaeetylae inhibitor LBH589 is a potent antimyeloma a- gent that overcomes drug resistance 显示文摘	MAISO P CARVAJAL-VERGARA X OCIO EM	2006	Cancer Res2006，66，11：	1
20	Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia:comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia,multiple myeloma and normal individuals显示文摘	Gutie?rrez NC Ocio EM de Las Rivas J		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示